Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-5-4
pubmed:abstractText
Hyperkinetic dystonia is characterized by phasic, tremulous, and "jerky" movements in addition to twisting postures. We studied longitudinally 23 index patients with hyperkinetic dystonia from a quaternary pediatric movement disorder clinic in Ireland. Four clinical categories emerged: (1) Eight patients were diagnosed with myoclonus-dystonia, of whom seven carried heterozygous epsilon sarcoglycan (SGCE) mutations, including a novel deletion of exon 10. Gait disorder, unsteadiness, or frequent falls before 18 months were detected in all SGCE mutation carriers, whereas the typical neck-predominant presentation developed only years later. (2) One patient classified as benign hereditary chorea, because jerks were choreiform and continuous rather than action-induced, carried a heterozygous stop mutation of the TITF-1 gene (Y114X, exon 2). (3) Three mutation-negative patients were grouped as "myoclonic dystonia" with jerks only in the body regions affected by dystonia. (4) Eleven patients presented with a novel combination of dystonia and low amplitude poly-mini myoclonus of the upper limbs and pectoral muscles (D-PMM). In early childhood up to 3 years of age, an initial presentation with predominant gait impairment with only subtle jerks should prompt consideration of SGCE mutation analysis in addition to testing for DYT1 mutations. A causative gene for D-PMM remains to be identified.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1531-8257
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
702-9
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:19117362-Adolescent, pubmed-meshheading:19117362-Adult, pubmed-meshheading:19117362-Age of Onset, pubmed-meshheading:19117362-Anticonvulsants, pubmed-meshheading:19117362-Antiparkinson Agents, pubmed-meshheading:19117362-Child, pubmed-meshheading:19117362-Child, Preschool, pubmed-meshheading:19117362-DNA Mutational Analysis, pubmed-meshheading:19117362-Dystonia, pubmed-meshheading:19117362-Exons, pubmed-meshheading:19117362-Female, pubmed-meshheading:19117362-Genetic Testing, pubmed-meshheading:19117362-Genotype, pubmed-meshheading:19117362-Humans, pubmed-meshheading:19117362-Hyperkinesis, pubmed-meshheading:19117362-Levodopa, pubmed-meshheading:19117362-Longitudinal Studies, pubmed-meshheading:19117362-Male, pubmed-meshheading:19117362-Middle Aged, pubmed-meshheading:19117362-Muscle, Skeletal, pubmed-meshheading:19117362-Mutation, pubmed-meshheading:19117362-Myoclonus, pubmed-meshheading:19117362-Nuclear Proteins, pubmed-meshheading:19117362-Phenotype, pubmed-meshheading:19117362-Sarcoglycans, pubmed-meshheading:19117362-Severity of Illness Index, pubmed-meshheading:19117362-Transcription Factors, pubmed-meshheading:19117362-Tyrosine, pubmed-meshheading:19117362-Young Adult
pubmed:year
2009
pubmed:articleTitle
"Jerky" dystonia in children: spectrum of phenotypes and genetic testing.
pubmed:affiliation
Department of Neurodegenerative Disease, Hertie-Institute for Clinical Brain Research, Center of Neurology, University of Tuebingen, Tuebingen, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't